Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 4
1986 13
1987 10
1988 27
1989 40
1990 49
1991 64
1992 62
1993 94
1994 88
1995 103
1996 79
1997 105
1998 91
1999 112
2000 113
2001 104
2002 103
2003 97
2004 120
2005 116
2006 126
2007 128
2008 131
2009 128
2010 117
2011 127
2012 120
2013 118
2014 90
2015 84
2016 64
2017 77
2018 61
2019 62
2020 54
2021 64
2022 45
2023 35
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

2,890 results

Results by year

Filters applied: . Clear all
Page 1
Raclopride, a new selective ligand for the dopamine-D2 receptors.
Hall H, Köhler C, Gawell L, Farde L, Sedvall G. Hall H, et al. Prog Neuropsychopharmacol Biol Psychiatry. 1988;12(5):559-68. doi: 10.1016/0278-5846(88)90001-2. Prog Neuropsychopharmacol Biol Psychiatry. 1988. PMID: 2975809 Review.
1. The use of raclopride, a new compound of the salicylamide series, as a ligand for the labelling of dopamine-D2 receptors in vitro and in vivo is described. 2. 3H-Raclopride has a high affinity for the dopamine-D2 receptors (Kd = 1 nM in rat striatum) with much le …
1. The use of raclopride, a new compound of the salicylamide series, as a ligand for the labelling of dopamine-D2 receptors in vitro …
Optimisation of [11C]Raclopride production using a Synthra GPextent system.
Perkins G, Sheth R, Greguric I, Pascali G. Perkins G, et al. Curr Radiopharm. 2014;7(2):100-6. doi: 10.2174/1874471007666141021111635. Curr Radiopharm. 2014. PMID: 25335809 Review.
The dopamine D2 receptor radiotracer [(11)C]Raclopride is used extensively in clinical and preclinical imaging. ...This work reports the optimisation of the production of [(11)C]Raclopride using a Synthra GPextent, comparing various methods. With optimised condition …
The dopamine D2 receptor radiotracer [(11)C]Raclopride is used extensively in clinical and preclinical imaging. ...This work reports …
Measuring amphetamine-induced dopamine release in humans: A comparative meta-analysis of [(11) C]-raclopride and [(11) C]-(+)-PHNO studies.
Caravaggio F, Porco N, Kim J, Torres-Carmona E, Brown E, Iwata Y, Nakajima S, Gerretsen P, Remington G, Graff-Guerrero A. Caravaggio F, et al. Synapse. 2021 May;75(5):e22195. doi: 10.1002/syn.22195. Epub 2021 Feb 1. Synapse. 2021. PMID: 33471400 Review.
Unfortunately, conflicting findings in the literature suggests that the dose of amphetamine they employed (0.3 mg/kg, p.o.) may not reliably reduce [(11) C]-raclopride binding in the caudate. Thus, it is unclear whether the preponderance of evidence supports the theory tha …
Unfortunately, conflicting findings in the literature suggests that the dose of amphetamine they employed (0.3 mg/kg, p.o.) may not reliably …
Striatal dopamine in anhedonia: A simultaneous [(11)C]raclopride positron emission tomography and functional magnetic resonance imaging investigation.
Phillips RD, Walsh EC, Zürcher NR, Lalush DS, Kinard JL, Tseng CE, Cernasov PM, Kan D, Cummings K, Kelley L, Campbell D, Dillon DG, Pizzagalli DA, Izquierdo-Garcia D, Hooker JM, Smoski MJ, Dichter GS. Phillips RD, et al. Psychiatry Res Neuroimaging. 2023 Aug;333:111660. doi: 10.1016/j.pscychresns.2023.111660. Epub 2023 Jun 1. Psychiatry Res Neuroimaging. 2023. PMID: 37301129
METHODS: Participants with (n = 25) and without (n = 12) clinically impairing anhedonia completed a reward-processing task during simultaneous positron emission tomography and magnetic resonance (PET-MR) imaging with [(11)C]raclopride, a DA D2/D3 receptor antagonist that s …
METHODS: Participants with (n = 25) and without (n = 12) clinically impairing anhedonia completed a reward-processing task during simultaneo …
Relationship between subjective well-being and aripiprazole: an [(11)C]raclopride PET study.
Kim S, Ock EY, Kwon JS, Kim E. Kim S, et al. Sci Rep. 2022 Jul 15;12(1):12106. doi: 10.1038/s41598-022-16130-5. Sci Rep. 2022. PMID: 35840763 Free PMC article.
Assessments including Positive and Negative Syndrome Scale (PANSS) and Subjective Well-being under Neuroleptics Scale (Kv-SWN) were administered. [(11)C]raclopride PET scan were conducted 2, 26, and 74 h after aripiprazole administration. ...
Assessments including Positive and Negative Syndrome Scale (PANSS) and Subjective Well-being under Neuroleptics Scale (Kv-SWN) were administ …
2,890 results